INTRODUCTION
malaria, deaths
MALARIA, ADVERSE EVENTS
Despite global investment of $2.7–$4.3 billion annually in malaria control, malaria cases and deaths were stable from 2015 to 2019A safe and effective malaria vaccine with sustained immunity across all age groups would be the most efficient way to decrease transmission and eliminate malaria from Bioko Island.This study evaluated the safety and immunogenicity of PfSPZ Vaccine in Equatoguinean participants aged 6 months to 61 years. It is the first trial to evaluate the safety of PfSPZ Vaccine in older adults and the second to provide a direct comparison of adverse events (AEs) and immunogenicity across multiple age strata.